With U.S. Funding Faltering, Europe May Be the Next Hub for Life Sciences Innovation

In the wake of NIH cuts and IPO slowdowns, Europe offers what the U.S. can’t right now: stability and scale.

Apr 06, 2025

∙ Paid

Welcome to the latest edition from FemmeHealth Ventures Alliance — delivering strategic insights into women’s health innovation and investment. We help you track emerging opportunities in Femtech and beyond, through a disciplined investor lens.

With U.S. Funding Faltering, Europe May Be the Next Hub for Life Sciences Innovation

In the wake of NIH cuts and IPO slowdowns, Europe offers what the U.S. can’t right now: stability and scale.

This post is for paid subscribers